Titre : Prostate

Prostate : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prostate : Questions médicales les plus fréquentes", "headline": "Prostate : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prostate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prostate" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Glandes exocrines", "url": "https://questionsmedicales.fr/mesh/D005088", "about": { "@type": "MedicalCondition", "name": "Glandes exocrines", "code": { "@type": "MedicalCode", "code": "D005088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A10.336" } } }, "about": { "@type": "MedicalCondition", "name": "Prostate", "alternateName": "Prostate", "code": { "@type": "MedicalCode", "code": "D011467", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "A A Kamalov", "url": "https://questionsmedicales.fr/author/A%20A%20Kamalov", "affiliation": { "@type": "Organization", "name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia." } }, { "@type": "Person", "name": "L M Samokhodskaya", "url": "https://questionsmedicales.fr/author/L%20M%20Samokhodskaya", "affiliation": { "@type": "Organization", "name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia." } }, { "@type": "Person", "name": "V K Karpov", "url": "https://questionsmedicales.fr/author/V%20K%20Karpov", "affiliation": { "@type": "Organization", "name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia." } }, { "@type": "Person", "name": "D A Okhobotov", "url": "https://questionsmedicales.fr/author/D%20A%20Okhobotov", "affiliation": { "@type": "Organization", "name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia." } }, { "@type": "Person", "name": "V N Mamedov", "url": "https://questionsmedicales.fr/author/V%20N%20Mamedov", "affiliation": { "@type": "Organization", "name": ") Faculty of Fundamental Medicine of Lomonosov Moscow State University, Department of Urology and Andrology, Moscow, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37338022", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6224" } }, { "@type": "ScholarlyArticle", "name": "Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.", "datePublished": "2023-01-21", "url": "https://questionsmedicales.fr/article/36681813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12931-023-02327-3" } }, { "@type": "ScholarlyArticle", "name": "Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.", "datePublished": "2022-08-16", "url": "https://questionsmedicales.fr/article/35974245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41585-022-00638-6" } }, { "@type": "ScholarlyArticle", "name": "Exosome Metabolic Patterns on Aptamer-Coupled Polymorphic Carbon for Precise Detection of Early Gastric Cancer.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35946596", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acsnano.2c05355" } }, { "@type": "ScholarlyArticle", "name": "Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37096575", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JU.0000000000003492" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tissus", "item": "https://questionsmedicales.fr/mesh/D014024" }, { "@type": "ListItem", "position": 3, "name": "Glandes exocrines", "item": "https://questionsmedicales.fr/mesh/D005088" }, { "@type": "ListItem", "position": 4, "name": "Prostate", "item": "https://questionsmedicales.fr/mesh/D011467" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prostate - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prostate", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prostate", "description": "Comment diagnostiquer un cancer de la prostate ?\nQuels tests sont utilisés pour évaluer la prostate ?\nQuand faut-il faire un dépistage de la prostate ?\nQuels symptômes indiquent un problème de prostate ?\nQuel rôle joue l'examen rectal ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prostate", "description": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?\nLa douleur pelvienne est-elle un symptôme courant ?\nComment reconnaître une infection de la prostate ?\nLes problèmes d'érection sont-ils liés à la prostate ?\nLe sang dans les urines est-il alarmant ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prostate", "description": "Peut-on prévenir le cancer de la prostate ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir les problèmes de prostate ?\nLe tabagisme influence-t-il le risque de cancer de la prostate ?\nLes examens réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prostate", "description": "Quels traitements existent pour le cancer de la prostate ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQu'est-ce que l'hormonothérapie ?\nLa radiothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prostate", "description": "Quelles sont les complications du cancer de la prostate ?\nLes traitements peuvent-ils causer des complications ?\nQuelles sont les conséquences d'une prostatite non traitée ?\nLe cancer de la prostate peut-il affecter d'autres organes ?\nComment gérer les complications après traitement ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prostate", "description": "Quels sont les principaux facteurs de risque du cancer de la prostate ?\nL'alimentation influence-t-elle le risque de cancer de la prostate ?\nLe surpoids est-il un facteur de risque ?\nLe niveau d'activité physique joue-t-il un rôle ?\nLes antécédents familiaux augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D011467?mesh_terms=Early+Detection+of+Cancer&page=10#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un cancer de la prostate ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par un examen rectal, un dosage du PSA et une biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la prostate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie, l'IRM et le dosage du PSA." } }, { "@type": "Question", "name": "Quand faut-il faire un dépistage de la prostate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage est recommandé à partir de 50 ans, ou 45 ans pour les personnes à risque." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de prostate ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés à uriner, des douleurs pelviennes ou du sang dans les urines peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quel rôle joue l'examen rectal ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'examen rectal permet de détecter des anomalies de la prostate, comme des nodules." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hypertrophie bénigne de la prostate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des mictions fréquentes, un jet urinaire faible et des urgences." } }, { "@type": "Question", "name": "La douleur pelvienne est-elle un symptôme courant ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur pelvienne peut être un symptôme de prostatite ou de cancer." } }, { "@type": "Question", "name": "Comment reconnaître une infection de la prostate ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les infections se manifestent par des douleurs, des mictions douloureuses et de la fièvre." } }, { "@type": "Question", "name": "Les problèmes d'érection sont-ils liés à la prostate ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles érectiles peuvent être liés à des problèmes de prostate ou à des traitements." } }, { "@type": "Question", "name": "Le sang dans les urines est-il alarmant ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la présence de sang dans les urines nécessite une évaluation médicale immédiate." } }, { "@type": "Question", "name": "Peut-on prévenir le cancer de la prostate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits, légumes et oméga-3 peut aider à réduire le risque." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir les problèmes de prostate ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut contribuer à maintenir une prostate en bonne santé." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque de cancer de la prostate ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de développer un cancer de la prostate." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des problèmes de prostate." } }, { "@type": "Question", "name": "Quels traitements existent pour le cancer de la prostate ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la radiothérapie et l'hormonothérapie." } }, { "@type": "Question", "name": "Comment traiter l'hypertrophie bénigne de la prostate ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements comprennent des médicaments, des thérapies minimales invasives et la chirurgie." } }, { "@type": "Question", "name": "Qu'est-ce que l'hormonothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hormonothérapie vise à réduire les niveaux d'hormones qui stimulent la croissance du cancer." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie est un traitement efficace pour le cancer localisé de la prostate." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des troubles urinaires, des dysfonctionnements érectiles et de la fatigue." } }, { "@type": "Question", "name": "Quelles sont les complications du cancer de la prostate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure la propagation du cancer, des douleurs chroniques et des problèmes urinaires." } }, { "@type": "Question", "name": "Les traitements peuvent-ils causer des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent entraîner des effets secondaires comme des troubles urinaires et érectiles." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une prostatite non traitée ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une prostatite non traitée peut entraîner des infections récurrentes et des douleurs chroniques." } }, { "@type": "Question", "name": "Le cancer de la prostate peut-il affecter d'autres organes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le cancer peut se propager aux os, aux ganglions lymphatiques et à d'autres organes." } }, { "@type": "Question", "name": "Comment gérer les complications après traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications peut inclure des médicaments, des thérapies physiques et un suivi médical." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du cancer de la prostate ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et l'origine ethnique." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de cancer de la prostate ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses animales peut augmenter le risque de cancer." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids et l'obésité sont associés à un risque accru de cancer de la prostate." } }, { "@type": "Question", "name": "Le niveau d'activité physique joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut augmenter le risque de développer un cancer de la prostate." } }, { "@type": "Question", "name": "Les antécédents familiaux augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir un parent proche atteint de cancer de la prostate augmente le risque personnel." } } ] } ] }

Sources (10000 au total)

Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.

Colorectal cancer (CRC) screening can help to reduce its incidence and mortality. Noninvasive strategies, such as plasma analysis of epigenetic alterations, can constitute important biomarkers of CRC ... This study aimed to evaluate the plasma methylation status of SEPT9 and BMP3 promoters as biomarkers for detection of CRC and its precursor lesions in a Brazilian population.... Plasma samples from 262 participants of the CRC screening program of Barretos Cancer Hospital who had a positive fecal occult blood test and underwent colonoscopy and cancer patients were analyzed. Pa... Among the 262 participants, 38 were diagnosed with CRC, 46 with advanced adenomas 119 with nonadvanced adenomas, three with sessile serrated lesions, and 13 with hyperplastic polyps. In 43 participant... The present study suggests that a combination of SEPT9 and BMP3 plasma methylation, along with age over 60 years, showed the highest performance in detecting CRC in a Brazilian population. These nonin...

Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.

Low-dose spiral computed tomography (LDCT) may not lead to a clear treatment path when small to intermediate-sized lung nodules are identified. We have combined flow cytometry and machine learning to ... Single cell suspensions prepared from induced sputum samples collected over three consecutive days were labeled with a viability dye to exclude dead cells, antibodies to distinguish cell types, and a ... Automated analysis combined with machine learning resulted in a predictive model that achieved an area under the ROC curve (AUC) of 0.89 (95% CI 0.83-0.89). The sensitivity and specificity were 82% an... CyPath Lung correctly classifies samples as cancer or non-cancer with high accuracy, including from participants at different disease stages and with nodules < 20 mm in diameter. This test is intended...

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.

The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer s... The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane D... The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsies, and biopsy tech... The evaluation of prostate cancer risk should be focused on the detection of clinically significant prostate cancer (Grade Group 2 or higher [GG2+]). The use of laboratory biomarkers, prostate MRI, an...

Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.

Early detection of bladder cancer (BCa) offers patients a favorable outcome and avoids the need for cystectomy. Development of an accurate and sensitive noninvasive BCa diagnostic test is imperative. ... CpG methylation microarray analysis was conducted on primary tumors with varying stages (T1-T4) and paired nontumor tissues from nine BCa patients. Bisulfite-pyrosequencing was performed to confirm th... CpG methylation microarray analysis and stepwise validation by bisulfite-pyrosequencing for tissues and urine sediments supported aberrant methylation sites of the PENK gene as potential biomarkers fo... In this study, we analyzed the comprehensive patterns of DNA methylation identified that PENK methylation possesses a high potential as a biomarker for urine-based early detection of BCa. Validation o...

Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study.

A grim prognosis of pancreatic cancer (PCa) was attributed to the difficulty in early diagnosis of the disease.... Identifying novel biomarkers for early detection of PCa is thus urgent to improve the overall survival rates of patients.... The study was performed firstly by identification of candidate microRNAs (miRNAs) in formalin-fixed, paraffin-embedded tissues using microarray profiles, and followed by validation in a serum-based co... We identified 27 miRNAs expressed differentially in PCa tissues as compared to the benign. Of which, the top-four was selected as a panel whose diagnostic efficacy was fully assessed in the serum spec... A panel of four serum miRNAs was developed showing remarkably discriminative ability of early stage PCa from either healthy controls or other pancreatic diseases, suggesting it may be developed as a n...

Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.

Early detection of breast cancer would help alleviate the burden of treatment for early-stage breast cancer and help patient prognosis. There is currently no established gene panel that utilizes the p... Following the PRISMA-ScR method, Pubmed and Google Scholar was searched for publications related to methylation biomarkers in breast cancer over a five-year period. Eligible publications were mined fo... Literature search identified 112 studies of which based on eligibility criteria, 13 studies were included. 28 potential methylation gene targets were identified, of which 23 were methylated at the pro... Our evaluation shows that at minimum APC, RASSFI, and FOXA1 genes would be a promising set of genes to start with for the early detection of breast cancer, based on the sensitivity and specificity out...

Oral cancer awareness campaign in Northern Germany: successful steps to raise awareness for early detection.

Oral cancer is an underestimated health problem, and its existence and the relevant prevention measures are not sufficiently known by the general population. The project thus aimed to develop, impleme... For each level, a campaign concept was developed and documented in terms of content and timing. The identified target group was elderly educationally disadvantaged male citizens ≥ 50 years. The evalua... The campaign was carried out from April 2012 to December 2014. The issue of awareness within the target group was significantly increased. Media coverage showed that regional media adopted the topic o... The development of the campaign concept with a comprehensive evaluation showed that the target group was successfully reached. The campaign was adapted to the required target group and specific condit...